[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567671":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":33,"centralContacts":34,"locations":43,"responsibleParty":59,"collaborators":33,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":65,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":33,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":92,"whyStopped":33,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"University of Seville","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Corticoesteroid Infiltrations","EXPERIMENTAL","In this group, participants will receive infiltrations directly into the affected plantar fascia. This intervention aims to reduce the inflammation and pain associated with plantar fasciopathy.",[13],"Drug: Infiltration",{"label":15,"type":16,"description":17,"interventionNames":18},"Conservative treatment","PLACEBO_COMPARATOR","Participants in this group will receive conservative treatment that does not include infiltrations. This approach is based on non-invasive methods that are commonly used to manage plantar fasciopathy.",[19],"Other: Conservative treatment",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Infiltration","The intervention consists of the administration of infiltrations in the affected plantar fascia of participants with a diagnosis of plantar fasciopathy. A drug such as a corticosteroid, PRP or hyaluronic acid will be used, which will be injected under ultrasound guidance to ensure precision at the site of the injury. This intervention aims to reduce inflammation and pain, thus improving the functionality of the foot. Up to three infiltrations will be performed, depending on the patient\\'s response to treatment and medical evaluation. The infiltrations will be compared with a control group that will receive conservative treatment without infiltrations, to evaluate the relative effectiveness of this pharmacological intervention in the management of plantar fasciopathy.",[9],[27],"Intervention group",{"type":6,"name":15,"description":29,"armGroupLabels":30,"otherNames":31},"The control group is used to compare the effectiveness of infiltrations with a non-invasive approach in the treatment of plantar fasciopathy. This group will not receive any infiltration and will focus on conservative interventions.",[15],[32],"Control group",null,[35,41],{"name":36,"role":37,"phone":38,"phoneExt":39,"email":40},"ANA MARIA RP DRA. ANA MARIA RAYO PEREZ, PRINCIPAL INVESTIGATOR","CONTACT","034-955-841-656","+34","anarayo43@gmail.com",{"name":42,"role":37,"phone":33,"phoneExt":33,"email":33},"RAQUEL GDP DRA. RAQUEL GARCIA DE LA PEÑA, PhD in Podiatry Science",[44],{"facility":45,"status":33,"city":46,"state":33,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Universidad de Sevilla","Seville","41009","Spain","ES",{"type":51,"coordinates":52},"Point",[53,54],-5.97317,37.38283,{"lat":54,"lon":53},[57],{"name":42,"role":37,"phone":33,"phoneExt":33,"email":58},"raquelgp@us.es",{"type":60,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":33,"oldOrganization":33},"PRINCIPAL_INVESTIGATOR","ANA MARIA RAYO PEREZ","Principal Investigator","100567671","effectiveness-of-infiltrations-in-the-treatment-of-plantar-fasciopathy-100567671",false,"NCT06671223","Effectiveness of Infiltrations in the Treatment of Plantar Fasciopathy","Effectiveness of Infiltrations in the Treatment of Plantar Fasciopathy: A Randomized Clinical Study.","INFILTRA-PLANT","Inclusion Criteria:\n\nAge: Participants aged 18 to 50 years. Diagnosis: Confirmed diagnosis of plantar fasciopathy based on clinical evaluation and imaging (if applicable).\n\nDuration of Symptoms: Symptoms persisting for at least 6 weeks prior to enrollment.\n\nPain Level: Reported pain level of at least 4 on the Visual Analog Scale (VAS) at baseline.\n\nAbility to Comply: Participants must be able to follow study protocols and attend follow-up appointments.\n\nInformed Consent: Participants must provide written informed consent to participate in the study.\n\nExclusion Criteria:\n\nOther Foot Pathologies: Presence of other significant foot conditions (e.g., fractures, arthritis, tarsal tunnel syndrome) that could interfere with the study results.\n\nPregnancy or Breastfeeding: Pregnant or breastfeeding individuals will be excluded from the study.\n\nNeurological Disorders: History of significant neurological disorders affecting lower limb function.\n\nSystemic Conditions: Patients with systemic conditions (e.g., diabetes, autoimmune diseases) that could affect healing or response to treatment.\n\nAllergy to Corticosteroids: Known allergy or adverse reaction to corticosteroids or local anesthetics.\n\nPsychiatric Disorders: Individuals with severe psychiatric disorders that may impair their ability to provide informed consent or adhere to the study protocol.","ALL","18 Years","50 Years",{"count":75,"type":76},200,"ESTIMATED","INTERVENTIONAL",[79],"NA","This clinical study aims to evaluate the effectiveness of infiltrations in the treatment of plantar fasciopathy, a painful condition that affects the sole of the foot and is common in active people. Plantar fasciopathy is caused by inflammation or damage to the plantar fascia, the tissue that connects the heel to the toes. Participants in this study will be randomly assigned to receive one of two treatments: corticosteroid infiltrations or conservative treatment without infiltrations. Infiltrations will be guided by ultrasound to ensure accuracy. The study will evaluate pain reduction and improvement in foot function over a six-month period. The objective of the study is to determine if infiltrations provide a significant improvement compared to other non-invasive treatments. The results will help doctors and patients make informed decisions about the best treatment options for plantar fasciopathy.",[82,83],"Plantar Fasciitis of Both Feet","Plantar Fasciopathy",[85,86,87,88,89,90,91],"plantar fasciitis","fasciopaty","corticosteroid","PRP","hyaluronic acid","infiltrations","treatment","NOT_YET_RECRUITING","2024-10-31",{"date":95,"type":96},"2024-11-04","ACTUAL",{"date":98,"type":76},"2025-06-01",{"date":100,"type":76},"2026-12-01",{"name":5,"class":6},1]